Menopause and hot flash clinical trials recruiting in the US
56 studies of hot flashes, menopause and perimenopause are recruiting women at US sites in 28 states: 21 test medicines, 12 test supplements, 4 test devices or procedures, 6 test behavior or lifestyle programs, 9 observe without giving a treatment, 4 study something else. Each is ClinicalTrials.gov's own record, read Nov 20, 2026 and every week after. First, who pays the costs of a trial.
Who pays when you join a trial
- The costs of a trial“Many clinical trial costs are covered by the sponsor of the study, a patient's insurance plan if one is available, and sometimes there are out-of-pocket costs.” (the National Cancer Institute's page (cancer.gov))
- The study's own costs“Research costs are those costs that are related to taking part in the trial. Often these costs are not covered by health insurance. But they may be covered by the trial’s sponsor.” (the National Cancer Institute's page (cancer.gov))
- Before you join“Before you join a study, ask the study coordinator which costs are covered and which are not.” (the National Cancer Institute's page (cancer.gov))
Trials of medicines (21)
| Study | What it tests | Ages | Recruiting in |
|---|---|---|---|
| Menopausal HT for Women Living With HIV (HoT)Phase 4, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT06856174 (clinicaltrials.gov) | Transdermal estradiol gel; Micronized Progesterone; Placebo for estradiol gel; Placebo for micronized progesterone | 40 to 60 | Alabama, California, Colorado, Georgia and 10 more23 US sites |
| Comparing Digital Therapy, Trazodone, and Daridorexant for Menopause-Related Insomnia SymptomsPhase 4, Brigham and Women's HospitalNCT07136415 (clinicaltrials.gov) | Cognitive behavioral therapy for insomnia (CBT-i); Trazodone; Daridorexant | 40 to 62 | Massachusetts, Michigan, Pennsylvania, Utah4 US sites |
| Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of MenopauseStratpharma AGNCT05672901 (clinicaltrials.gov) | StrataMGT; Estrace 0.01% Vaginal Cream | 18 and older | California, Florida, Georgia3 US sites |
| Finding Links Between Hot flASHes and CardioVascular DiseasePhase 2, Massachusetts General HospitalNCT07077395 (clinicaltrials.gov) | elinzanetant - reference formulation; placebo | 40 to 65 | Massachusetts2 US sites |
| FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine TherapyPhase 2, Yale UniversityNCT06917313 (clinicaltrials.gov) | Fezolinetant; Placebo | 18 and older | Connecticut1 US site |
| Proof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal WomenPhase 2, Azure Biotech Inc.NCT06197568 (clinicaltrials.gov) | Lasofoxifene Tartrate | 45 to 60 | Minnesota1 US site |
| Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).Phase 2, Tioga PharmaceuticalsNCT07042516 (clinicaltrials.gov) | Asimadoline | 40 to 62 | Georgia1 US site |
| Role of Menopause in ThermoregulationPhase 4, Penn State UniversityNCT06798571 (clinicaltrials.gov) | Elagolix Oral Tablet; Estradiol patch; cellulose placebo; placebo patch | 42 to 64 | Pennsylvania1 US site |
| VEDA Study (DHEA vs Estradiol)University of ArizonaNCT07574216 (clinicaltrials.gov) | DHEA ovals; Estradiol 0.01% Vag Cream | 40 to 90 | Arizona1 US site |
| Cyclic vs. Constant Estradiol: Regimens' Effects on Brain HealthPhase 4, University of Colorado, DenverNCT07831499 (clinicaltrials.gov) | Cyclic Estradiol; Continuous Estradiol | 38 to 60 | Colorado1 US site |
| Impact of Early Aging and Menopause on the Vascular Responses to HypoxiaEarly phase 1, University of Missouri-ColumbiaNCT06417177 (clinicaltrials.gov) | Placebo; Propranolol; Gemtesa | 18 to 70 | Missouri1 US site |
| A Study to Assess the Skin Irritation and Sensitization of Estradiol/Levonorgestrel TDS in Healthy Postmenopausal SubjectsPhase 1, Corium Innovations, Inc.NCT07794150 (clinicaltrials.gov) | Estradiol/Levonorgestrel Transdermal System | 40 to 75 | Nevada1 US site |
| Beta3-adrenergic Receptors and Cardiovascular Function in Aging WomenEarly phase 1, University of Missouri-ColumbiaNCT07674680 (clinicaltrials.gov) | Placebo; Gemtesa | 18 to 70 | Missouri1 US site |
| Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal FemalesPhase 1, University of ConnecticutNCT07365514 (clinicaltrials.gov) | Blackcurrant (BC) extract; Blackcurrant (BC) extract; Placebo | 45 to 70 | Connecticut1 US site |
| Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialPhase 2, University of Michigan Rogel Cancer CenterNCT07158021 (clinicaltrials.gov) | Biospecimen Collection; Electronic Health Record Review; Goserelin; Leuprolide | 18 and older | Michigan1 US site |
| Hot Flashes and Neurovascular Function in WomenMayo ClinicNCT05193968 (clinicaltrials.gov) | Sympathoexcitatory stressors; Sodium Nitroprusside; Acetylcholine; Terbutaline | 40 to 60 | Minnesota1 US site |
| Effects of Hemp-Derived Cannabinoids on Menopause SymptomsPhase 2, Washington State UniversityNCT07393672 (clinicaltrials.gov) | Hemp-derived cannabinoids; Placebo | 40 to 60 | Washington1 US site |
| Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsPhase 2, University of ArkansasNCT01530373 (clinicaltrials.gov) | solifenacin; Clonidine | 18 and older | Arkansas1 US site |
| Sympathetic Vascular Transduction Across the Menopause Transition: Contributing MechanismsEarly phase 1, University of Missouri-ColumbiaNCT06787066 (clinicaltrials.gov) | Propranolol Hydrochloride; Phentolamine Injection | 18 to 70 | Missouri1 US site |
| Cardiometabolic Consequences of the Loss of Ovarian FunctionPhase 4, University of Colorado, DenverNCT06264882 (clinicaltrials.gov) | Degarelix; Transdermal Estradiol Patch; Transdermal Placebo Patch | 20 to 45 | Colorado1 US site |
| Bioenergetic Effects of Aging and Menopause (BEAM)Phase 4, University of Colorado, DenverNCT04043520 (clinicaltrials.gov) | GnRH antagonist; Estrogen Product; Placebo estradiol; Placebo GnRH antagonist | 40 to 65 | Colorado1 US site |
Trials of supplements (12)
| Study | What it tests | Ages | Recruiting in |
|---|---|---|---|
| Haelan 951 for Menopause Symptoms in Peri- and Postmenopausal WomenSpectrum Clinical Research, LLCNCT07751029 (clinicaltrials.gov) | Haelan 951 | 45 to 65 | Missouri1 US site |
| Effects of Amylopectin Chromium Blend on Whole-Body Protein Kinetics and Glucose in Peri/Post-Menopausal WomenNutrition 21, Inc.NCT07402382 (clinicaltrials.gov) | Amylopectin-chromium blend; Concentrated Amylopectin-chromium blend; Placebo | 40 to 70 | Ohio1 US site |
| Satavari and Ashoka for Menopause (SAM) StudyVidya USA CorporationNCT07861295 (clinicaltrials.gov) | Ashoka Bark and Shatavari; Placebo | 40 to 65 | Florida1 US site |
| Randomized Evaluation of Natural Extract for Menopausal Wellness (RENEW)India Glycols LtdNCT07834463 (clinicaltrials.gov) | Shatavari (Asparagus racemosus) Extract; Placebo | 45 to 60 | Florida1 US site |
| Study on Allopregnanolone and Depression in Women Across the Menopause TransitionBeth Israel Deaconess Medical CenterNCT06238700 (clinicaltrials.gov) | pregnenolone; placebo | 40 to 60 | Massachusetts1 US site |
| Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical TrialMayo ClinicNCT06826755 (clinicaltrials.gov) | Terry Naturally® melatonin 5mg SR; Placebo | 40 to 55 | Minnesota1 US site |
| Prebiotic Inulin for Late-Reproductive IndividualsGeorge Washington UniversityNCT07724522 (clinicaltrials.gov) | Inulin; Maltodextrin (Placebo) | 40 to 55 | District of Columbia1 US site |
| Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal FemalesUniversity of VirginiaNCT06480695 (clinicaltrials.gov) | Nitrate-Rich Beetroot Juice; High Intensity Exercise; Moderate Intensity Exercise; Nitrate-Depleted Placebo Beetroot Juice | 45 to 75 | Virginia1 US site |
| Prunes Preventing Bone Loss in PerimenopausePenn State UniversityNCT07120997 (clinicaltrials.gov) | Prunes; Calcium supplement; Vitamin D Supplement | 44 to 55 | Pennsylvania1 US site |
| JDS-HF3.0 Supplementation on Menopause Related Quality of Life Outcomes in Postmenopausal WomenBonafide HealthNCT07238478 (clinicaltrials.gov) | JDS-HF3.0; Placebo | 50 to 70 | New York1 US site |
| A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).Olly, PBCNCT07033013 (clinicaltrials.gov) | Placebo; Dietary Supplement with actives | 40 to 65 | California1 US site |
| Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled StudySF Research Institute, Inc.NCT06716554 (clinicaltrials.gov) | Shatavari extract; Shatavari + Ashwagandha extract; Placebo | 45 to 55 | California1 US site |
Trials of devices and procedures (4)
| Study | What it tests | Ages | Recruiting in |
|---|---|---|---|
| VALOR: Vaginal Atrophy & Long-term Observation of RecoveryStratpharma AGNCT05953090 (clinicaltrials.gov) | 7-0940 | 18 and older | Alabama, California, North Carolina, South Carolina and 1 more6 US sites |
| A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal StagesGalderma R&DNCT07342400 (clinicaltrials.gov) | Sculptra® | 22 and older | Florida, New York2 US sites |
| MenoZen VR for Menopause Symptom ManagementMayo ClinicNCT07633743 (clinicaltrials.gov) | MenoZen | 45 to 60 | Florida1 US site |
| Time-Efficient Inspiratory Muscle Strength Training for Reducing Sympathetic Activity and Improving Sleep in Midlife WomenMayo ClinicNCT06743269 (clinicaltrials.gov) | High-Resistance Inspiratory Muscle Strength Training; Low-Resistance Inspiratory Muscle Strength Training; POWERbreathe K3 device | 45 to 60 | Minnesota1 US site |
Trials of behavior and lifestyle programs (6)
| Study | What it tests | Ages | Recruiting in |
|---|---|---|---|
| Hemodynamics After Resistance TrainingUniversity of MichiganNCT07022340 (clinicaltrials.gov) | Resistance Training Intervention | 40 to 60 | Michigan1 US site |
| Impact of Lean Pork on Endothelial Function in PerimenopausePennington Biomedical Research CenterNCT06976112 (clinicaltrials.gov) | Pork Diet; Plant Diet | 40 to 55 | Louisiana1 US site |
| Sleep and Light Intervention (SALI) for Menopausal Mood DysfunctionUniversity of California, San DiegoNCT06678880 (clinicaltrials.gov) | Phase Advanced Intervention (PAI); Phase Delay Intervention (PDI) | 45 to 75 | California1 US site |
| Amygdala Insula Retraining in the Management of Perimenopause SymptomsChronic Conditions Research FundNCT07427459 (clinicaltrials.gov) | Amygdala and Insula Retraining (AIR) | 38 to 60 | Iowa1 US site |
| Improving Outcomes in Early Menopause After CancerDuke UniversityNCT06982677 (clinicaltrials.gov) | Nurse Navigator Intervention; Education Control | 18 to 44 | North Carolina1 US site |
| Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia RiskUniversity of ChicagoNCT06965686 (clinicaltrials.gov) | PERI-MIND | 40 to 58 | Illinois1 US site |
Observational studies (no treatment given) (9)
| Study | What it tests | Ages | Recruiting in |
|---|---|---|---|
| The Immunobiological Mechanisms of Depression in PerimenopauseVan Andel Research InstituteNCT07910552 (clinicaltrials.gov) | not stated | 40 to 55 | Michigan, New York3 US sites |
| Effects of Estrogen on Heart Health in Women With Primary Ovarian InsufficiencyMassachusetts General HospitalNCT06866119 (clinicaltrials.gov) | not stated | 30 to 40 | Massachusetts1 US site |
| Menopausal Hormone Therapy And Left Ventricular FunctionMayo ClinicNCT07242391 (clinicaltrials.gov) | Menopausal Hormone Therapy | 45 to 60 | Minnesota1 US site |
| CREST: Samphire Guided Care Program on Wellbeing, Work Productivity, and Quality of LifeSamphire Group, Inc.NCT07679074 (clinicaltrials.gov) | Lutea Transcranial Direct Current Stimulation (tDCS) Device; Samphire Guided Care Program | 18 to 65 | California1 US site |
| Menopause Transition, Sex Hormone Deficiency and Autonomic and Vascular FunctionUniversity of MinnesotaNCT06490146 (clinicaltrials.gov) | No intervention | 45 to 55 | Minnesota1 US site |
| The Cardiovascular Impact of Hot FlushesUniversity of MinnesotaNCT05251324 (clinicaltrials.gov) | Hot Flush Induction | 40 to 70 | Minnesota1 US site |
| The Synergistic Effects of Menopause and HIV on Cardiovascular Disease Risk in WomenUniversity of California, San FranciscoNCT07284082 (clinicaltrials.gov) | Whole body MRI | 18 and older | California1 US site |
| Autonomic Regulation of Blood Pressure in Premature and Early Menopausal WomenUniversity of MinnesotaNCT04439370 (clinicaltrials.gov) | Microneurography to measure muscle sympathetic nerve activity (MSNA); Baroreflex sensitivity testing; Sympathoexcitatory Maneuvers; Blood tests | 35 to 70 | Minnesota1 US site |
| Apple Women's Health StudyApple Inc.NCT04196595 (clinicaltrials.gov) | not stated | 18 and older | Massachusetts1 US site |
Other studies (4)
| Study | What it tests | Ages | Recruiting in |
|---|---|---|---|
| Hydration & Female Life StagesPepsiCo Global R&DNCT07653620 (clinicaltrials.gov) | placebo beverage; electrolyte beverage | 18 to 60 | Florida, New York2 US sites |
| Sex Hormones and AgingUniversity of MichiganNCT07848438 (clinicaltrials.gov) | HRT: High-Resistance Strength Training; Control: High-Resistance Strength Training | 50 to 70 | Michigan1 US site |
| Thermoregulatory Physiology of Menopausal Hot FlashesSRI InternationalNCT07824648 (clinicaltrials.gov) | Intervention C (Targeted skin cooling); Intervention B (Ambient cooling); Intervention A (Room temperature) | 40 to 65 | California1 US site |
| Vaginal Changes After CO2 LaserUniversity of California, IrvineNCT06691178 (clinicaltrials.gov) | Optical coherence tomography (OCT) | 18 and older | California1 US site |
By state: where these studies recruit
| State | Studies | Cities |
|---|---|---|
| California | 10 | Laguna Hills, Burbank, Newport Beach, San Diego, Irvine, San Francisco and 3 more |
| Minnesota | 8 | Minneapolis, Rochester, Saint Paul |
| Florida | 6 | Miami, Jacksonville, Bradenton, New Port Richey |
| Massachusetts | 6 | Boston |
| Michigan | 5 | Ann Arbor, Novi, Grand Rapids, Kalamazoo |
| Missouri | 5 | Columbia, St Louis, Kansas City |
| New York | 5 | New York, Harrison, Valhalla |
| Colorado | 4 | Aurora |
| Pennsylvania | 4 | University Park, Philadelphia, Pittsburgh |
| Georgia | 3 | Johns Creek, Atlanta |
| North Carolina | 3 | Fayetteville, Chapel Hill, Greensboro, Durham |
| Alabama | 2 | Birmingham |
| Connecticut | 2 | New Haven, Storrs |
| Illinois | 2 | Chicago |
| Ohio | 2 | Cincinnati, Cleveland, Columbus, Canfield |
| Texas | 2 | Dallas, Houston |
| Arizona | 1 | Phoenix |
| Arkansas | 1 | Little Rock |
| District of Columbia | 1 | Washington D.C. |
| Iowa | 1 | Decorah |
| Louisiana | 1 | Baton Rouge |
| Maryland | 1 | Baltimore |
| Nevada | 1 | Las Vegas |
| New Jersey | 1 | Newark |
| South Carolina | 1 | West Columbia |
| Utah | 1 | Salt Lake City |
| Virginia | 1 | Charlottesville |
| Washington | 1 | Pullman |
From ClinicalTrials.gov (clinicaltrials.gov), the US government's registry of studies: recruiting studies of hot flashes, vasomotor symptoms, menopause, perimenopause and the vaginal symptoms of menopause, open to women, with a US site recruiting. Read every Thursday; a study that stops recruiting leaves this page.
Menopause clinical trials: common questions
Are there menopause clinical trials near me?
56 menopause, perimenopause and hot flash studies are recruiting women at US sites, in 28 states. The most are in California (10), Minnesota (8), Florida (6), Massachusetts (6), Michigan (5). The table by state on this page lists them; each study's own record on ClinicalTrials.gov names its sites and contacts.
Do menopause clinical trials pay you?
The trial records do not say, so this page does not either: ask the study's contact. On costs, the National Cancer Institute says many trial costs are covered by the study's sponsor, a patient's insurance plan, and sometimes out of pocket, and that research costs such as the study drug may be covered by the sponsor.
Are there clinical trials of hot flash medicines?
5 trials recruiting in the US test a medicine for hot flashes, among them solifenacin and Clonidine (phase 2); Sympathoexcitatory stressors and Sodium Nitroprusside; Fezolinetant (phase 2); Asimadoline (phase 2); elinzanetant - reference formulation (phase 2). Each is listed with its phase and sites on this page.
Are there perimenopause clinical trials?
9 of the recruiting studies name perimenopause in their title or conditions: Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial; Impact of Lean Pork on Endothelial Function in Perimenopause; Hemodynamics After Resistance Training; Prunes Preventing Bone Loss in Perimenopause.